This article outlines the management strategy for the administration of the new anti-cancer drug cetuximab (Erbitux) in this case to private patients in Dorset using an independent service provider (Healthcare at Home) to administer the drug. Use of cetuximab in cancer care seems set to increase and this will place significant demand on the capacity of chemotherapy units. A strategy of home administration – or perhaps in a satellite chemotherapy unit – after initial exposure is feasible
Cancer Nursing Practice. 5, 4, 28-29. doi: 10.7748/cnp2006.05.5.4.28.c194
Conflict of interestThe author has received honoraria from Pfizer and Merck, and hospitality from Healthcare at Home
Peer reviewThis article has been subject to double blind peer review
Keywords :
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
